Previous 10 | Next 10 |
Maravai LifeSciences Holdings press release ( NASDAQ: MRVI ): Q2 GAAP EPS of $0.53 beats by $0.15 . Revenue of $242.73M (+11.5% Y/Y) beats by $9.51M . Shares -4.98% . For further details see: Maravai LifeSciences Holdings GAAP EPS of $0.53 beats b...
SAN DIEGO, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the second quarter ended June 30, 2022, tog...
There's a reason why the Rocky movies were so successful: Nearly everybody loves a comeback. That isn't just true in entertainment; investors like comeback stories, too. We asked three Motley Fool contributors to pick beaten-down stocks that they think could soar in the second half ...
SAN DIEGO, July 19, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its second quarter 2022 financial and operating results after the market clo...
SAN DIEGO, July 06, 2022 (GLOBE NEWSWIRE) -- TriLink BioTechnologies (TriLink), a Maravai LifeSciences company (Maravai) (NASDAQ: MRVI) and a leader in the production of nucleic acids for research, diagnostics and therapeutics applications, today announced that Kate Broderick, Ph.D., has jo...
Peter Leddy has joined Maravai LifeSciences (NASDAQ:MRVI) as executive vice president and chief administrative officer. He had been serving as a consultant to the company. In the newly created role, Leddy will be responsible for global shared services functions, such as human resources, envir...
SAN DIEGO, June 27, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced today that Peter Leddy, Ph.D. (“Pete”) has joined the Company as Executive Vice ...
SAN DIEGO, May 24, 2022 (GLOBE NEWSWIRE) -- TriLink BioTechnologies (TriLink), a Maravai LifeSciences company (Maravai) (NASDAQ: MRVI), and a leader in the production of nucleic acids for research, diagnostics and therapeutics applications, today announced a Cooperative Agreement with the A...
SAN DIEGO, May 11, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conferences during the months of May and June. On...
Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2022 Earnings Conference Call May 05, 2022, 05:00 PM ET Company Participants Deb Hart - Head of Investor Relations Carl Hull - Chief Executive Officer Kevin Herde - Executive Vice President and Chief Financial Officer Conference Call Participants ...
News, Short Squeeze, Breakout and More Instantly...
Maravai LifeSciences Holdings Inc. Company Name:
MRVI Stock Symbol:
NASDAQ Market:
Maravai LifeSciences Holdings Inc. Website:
2024-07-25 20:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
SAN DIEGO, July 10, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its second quarter 2024 financial and operating results after the market closes on...
- Highlights progress across four priority areas and commitment to environmentally and socially responsible growth. - Conducted first stakeholder assessment to identify and prioritize ESG issues that are most important for Maravai and our stakeholders. - Increased the sc...